Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis
- PMID: 18253025
- DOI: 10.1159/000114869
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
